Strong EU Trade Provisions On IP Seen As Threat To Poor Nations’ Medicines Access 18/02/2009 by David Cronin for Intellectual Property Watch 2 Comments BRUSSELS – Efforts by the European Union to insert strong provisions on pharmaceutical patents in a series of free trade agreements it is negotiating could imperil access to medicines in developing countries, global public health activists have alleged. As part of trade talks being conducted with India, Colombia, Peru and a regional grouping in south-east Asia, EU officials have proposed that drug-makers should benefit from a robust intellectual property regime. National regulatory authorities in the countries concerned would be prevented for lengthy periods from using data provided by a company that holds a drug patent in order to authorise a generic version of that medicine.
Proposed EU Copyright Term Extension Faces Vocal Opposition In Parliament 27/01/2009 by David Cronin for Intellectual Property Watch 8 Comments By David Cronin for Intellectual Property Watch BRUSSELS – Strong opposition is being voiced by members of the European Parliament over plans to extend the copyright protection applying to sound recordings from 50 to 95 years. Both left and right-leaning Parliament members (MEPs) have signalled that they intend to vote against the proposed extension at […]
Lamy invita a los Miembros de la OMC descontentos a que usen el examen del Acuerdo sobre los ADPIC y la Salud Pública 12/12/2008 by Catherine Saez, Intellectual Property Watch Leave a Comment Por William New Se afirma hace un tiempo que no están funcionando las disposiciones de la Organización Mundial del Comercio (OMC) destinadas a incrementar el acceso a los medicamentos de los países pobres. En respuesta a estas afirmaciones, el Director General de la OMC, Pascal Lamy, comentó el pasado martes que si los Miembros están […]
Pascal Lamy invite les membres de l’OMC mécontents à utiliser le réexamen de l’Accord sur les ADPIC et la santé publique 12/12/2008 by Catherine Saez, Intellectual Property Watch Leave a Comment Par William New Mardi, face aux allégations de longue date qui nient l’efficacité des règles de l’Organisation mondiale du commerce (OMC) visant à améliorer l’accès aux médicaments dans les pays pauvres, le Directeur général de l’OMC, Pascal Lamy, a appelé les membres mécontents à utiliser le mécanisme de réexamen annuel de ces règles. « C’est […]
Accélération des efforts de l’Afrique dans la lutte anti-contrefaçon menée par les pays développés 12/12/2008 by Catherine Saez, Intellectual Property Watch Leave a Comment Par Nick Wadhams pour Intellectual Property Watch NAIROBI, KENYA – Suite à la crainte d’un déferlement sur l’Afrique de contrefaçons de médicaments et de pesticides, l’organisme international chargé de l’application des lois INTERPOL ouvre la voie vers un renforcement des efforts et des moyens pour que les autorités soient conscientes de la menace planant sur […]
WHO Members Slow To Bridge Disagreements At Pandemic Flu Meeting 11/12/2008 by Kaitlin Mara for Intellectual Property Watch 1 Comment By Kaitlin Mara Four days into one-week “critical” negotiations on pandemic influenza preparedness, World Health Organization members had yet to tackle areas of core disagreement and participants were expressing doubt as to whether consensus can be achieved by week’s end. Details on the definition of “Pandemic Influenza Preparedness (PIP) Biological Materials,” on the content of […]
Generic Drugmakers, Activists Praise Lamy; Gurry Defends ‘Respect’ For IP 11/12/2008 by William New, Intellectual Property Watch Leave a Comment By William New Generic pharmaceutical producers have grown in importance in recent years despite or because of intellectual property rights, and at their annual meeting this week in Geneva they attracted the leaders of the primary intergovernmental institutions engaged in IP rights policy. Generic industry representatives and access to medicines activists praised an opening speech […]
An Alternative Proposal For Enhancing Developing Country Access To Patented Medicines 10/12/2008 by Wagdy Sawahel for Intellectual Property Watch Leave a Comment By Wagdy Sawahel for Intellectual Property Watch An intellectual property model intended to preserve the structure of patent protection while adding balance for developing countries has been proposed to provide incentives for innovators to contribute toward the alleviation of suffering in developing countries in dire need of patented medicines largely owned by rich countries. This […]
Lamy Challenges Discontented WTO Members To Use TRIPS Public Health Review 09/12/2008 by William New, Intellectual Property Watch Leave a Comment By William New Confronted with longstanding assertions that World Trade Organization rules intended to bring greater access to medicines to poor countries are not working, WTO Director General Pascal Lamy said Tuesday discontented members should use the annual review of those rules if they have a complaint. “It is precisely to address these kinds of […]
Droits de propriété intellectuelle et organismes génétiquement modifiés : une combinaison fatale selon les activistes 09/12/2008 by Catherine Saez, Intellectual Property Watch Leave a Comment Par Catherine Saez L’extension des brevets aux organismes génétiquement modifiés (OGM) et leur production dans de nombreux pays menacent les droits des agriculteurs et la biodiversité, la sécurité alimentaire dépendant de plus en plus d’une poignée d’entreprises transnationales de biotechnologie, selon les intervenants à un atelier qui s’est déroulé récemment à Genève. L’atelier a été […]